Related to this topic: Leaflets | Support | Patient+ | News | Weblinks | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Nephrotic Syndrome

Description

Nephrotic syndrome is a pattern of presentation of renal disease, rather than a single pathological entity or diagnosis. It comprises the following elements:

Features of the nephrotic syndrome:

  • Glomerular dysfunction leading to excessive urinary protein excretion (formerly defined as >3.5 g/day but there appears to be individual variation around this cut-off figure)
  • Hypoalbuminaemia as a result of urinary protein loss (albumin levels usually in range <25–30 g/l)
  • Peripheral oedema due to hypoalbuminaemia
  • Hypercholesterolaemia/dyslipidaemia
  • Normal detoxifying renal function, at least initially

The primary abnormality in nephrotic syndrome is thought to be loss of a layer of negatively-charged heparan sulphate within the glomerular basement membrane, that allows the increased passage of large amounts of low-molecular weight anionic proteins during ultrafiltration. However, recent research has shown that the loss of albumin in the urine may not be due to excessive filtration across the glomerular basement membrane as was previously supposed, rather a failure to reabsorb albumin after its ultrafiltration. It appears that renal disease may cause an impairment of the ability of cells in the proximal renal tubules to endocytose albumin that has been filtered across the glomeruli, and deliver it back into the blood supply around the renal tubules.1

Oedema is thought to occur due to the loss of plasma oncotic pressure secondary to hypoalbuminaemia, causing accumulation of fluid in the extracellular space; a decrease in intravascular volume is thought to cause renal hypoperfusion further enhancing salt and water retention. However, this model cannot fully explain all the pathophysiological and clinical features of the nephrotic syndrome and other, as yet unelucidated, intra- and extra-renal mechanisms may be responsible for the combination of biochemical and clinical features seen in nephrotic syndrome. Hypercholesterolaemia is thought to be caused by:

  • Stimulation of the liver to increase synthesis of all plasma proteins (including the lipoproteins), due to their low level in the blood.
  • Reduction of lipoprotein catabolism due to reduced levels of lipoprotein lipase in blood.

Other consequences of nephrotic syndrome:2

  • Decreased resistance to infections due to urinary immunoglobulin loss.
  • Increased risk of arterial and venous thrombosis due to loss of anti-thrombin III and plasminogen in the urine, combined with an increase in hepatic synthesis of clotting factors.
  • Increased risk of osteitis fibrosa cystica and osteomalacia due to loss of vitamin D-binding protein and its complexes in the urine, through a combination of calcium malabsorption and secondary hyperparathyroidism.

Epidemiology

In the US, its annual incidence among children is reported to be 2–7 cases per 100,000.2 Incidence varies among adults depending on the incidence of underlying causes for the condition, particularly diabetes mellitus.

Commoner causes of the nephrotic syndrome

Primary renal diseases

Secondary renal diseases

Presentation

Symptoms

  • In children facial swelling is a common presenting feature, with periorbital oedema often being the first evidence that something is wrong; oedema may progress to involve the whole body.
  • Adults tend to present with peripheral oedema affecting the ankles and legs, which may progress to involve the whole body.
  • Some patients may notice frothiness of their urine.
  • Hypercoagulability may manifest as venous or arterial thrombosis, e.g. DVT, MI.
  • Recurrent infections and/or general fatigue, lethargy, poor appetite, weakness or episodic abdominal pain may cause presentation to a doctor.

Signs

Investigations
  • To find underlying cause of syndrome, direct future management and establish baseline of severity/monitor response to treatment
  • Urinalysis and urine microscopy/culture and sensitivity
  • Urinary protein:urinary creatinine ratio
  • Light-chain urinary protein excretion (?myeloma)
  • 24-hour urinary protein excretion
  • U&E, creatinine
  • Serum albumin
  • Serum lipids
  • FBC
  • Hepatitis B and C serology
  • Serology for other possible infective aetiologies including HIV if thought relevant
  • Cryoglobulins/serum protein electrophoresis/autoantibody profile if relevant
  • CXR to exclude malignancy and exclude other causes of oedema
  • Renal tract ultrasound to assess size and structural condition of kidneys (obstructed or small kidneys may contraindicate renal biopsy).

Most cases will require renal biopsy to determine the exact underlying cause of the condition; children under 8 years old usually have minimal-change nephrotic syndrome and so may be spared this investigation, especially if they are steroid-responsive. Adults with an obvious cause (e.g. diabetes with evidence of other complications) may be spared a biopsy at the discretion of a renal specialist. Other investigations to diagnose less usual causes such as abdominal fat/gingival biopsy to detect amyloidosis may be needed in place of or in addition to a renal biopsy.

Initial management of nephrotic syndrome
  • Most cases do not require acute hospitalisation.
  • Indications for acute admission include:
    • Severe generalised oedema, particularly if pleural effusion/oedema causing respiratory compromise
    • Tense scrotal/labial oedema
    • Complications of the nephrotic state (e.g. sepsis, pneumonia, MI, DVT, growth failure)
    • Inability to comply with therapy/inability to cope with condition in family/independently
    • Any features of a possible nephritic syndrome such as haematuria, hypertension and impaired renal function parameters
  • Reduce salt intake in diet (avoid processed foods and adding salt to food).
  • Give diet with adequate calorific intake and sufficient protein content (1–2 g/kg daily).3
  • Hyperlipidaemia – does not initially require therapy but may do so if prolonged.3
  • Fluid restriction is not usually necessary (if severe enough to need this then may need admission).3
  • Referral to a renal service for urgent outpatient assessment is advisable, to confirm the mode of presentation and direct any future investigations/therapy.
  • Oedema is treated through diuretic therapy with furosemide (~1mg/kg/day) ± spironolactone (~2mg/kg/day).
  • Check weight regularly to assess response to diuretics and ensure fluid retention is not worsening, or that patient is over-diuresed.
  • Patients with very low albumin levels may not respond to diuretics and may require admission to receive intravenous albumin therapy.
  • Some children with severe oedema may be prescribed antibiotic prophylaxis against infection and this should usually be on the advice of a renal specialist.
  • Most children will have minimal-change nephrotic syndrome and usually respond to a trial of steroid therapy under the direction of a renal specialist.
  • Other forms of nephrotic syndrome are less treatment responsive; ACE inhibitors are frequently used in adults to some effect.
  • In children who do not respond to steroids, and in some adults, treatment may be with other immunomodulatory drugs such as cyclophosphamide, cyclosporin and levamisole.
Prognosis
  • This is highly variable depending on the underlying cause.
  • Congenital nephrotic syndrome usually carries a very poor prognosis.
  • Outlook for the vast majority of children with minimal-change nephrotic syndrome is excellent; response to steroids is the norm, although there may be relapses and a need to use alternative immunomodulatory drugs.
  • Adult prognosis is variable and largely related to the underlying cause, its severity, progression and response to any treatment used to modify it.


Document References
  1. Russo LM, Sandoval RM, McKee M, et al; The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: Retrieval is disrupted in nephrotic states. Kidney Int. 2007 Jan 17;. [abstract]
  2. Agraharkar M, Gala G, eMedicine, Nephrotic Syndrome, 2006.
  3. Travis L, eMedicine, Nephrotic Syndrome, 2005; Paediatric overview

Internet and Further Reading
  • Medline Plus - Acute Nephritic Syndrome
  • Acute nephritis (GPN)
  • Medline Plus - Nephrotic syndrome.
  • EdREN, website of renal unit of the Royal Infirmary of Edinburgh, information for patients on the nephrotic syndrome, 2006.
  • Loghman-Adham M; Evaluating proteinuria in children. Am Fam Physician. 1998 Oct 1;58(5):1145-52, 1158-9. [abstract]
  • Carroll MF, Temte JL; Proteinuria in adults: a diagnostic approach. Am Fam Physician. 2000 Sep 15;62(6):1333-40. [abstract]
  • Travis L, eMedicine, Nephrotic Syndrome, 2005; Paediatric overview
  • Hogg RJ, Portman RJ, Milliner D, et al; Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics. 2000 Jun;105(6):1242-9. [abstract]
  • Carome MA, Moore J Jr; Nephrotic syndrome in adults. A diagnostic and management challenge. Postgrad Med. 1992 Aug;92(2):209-15, 218, 220. [abstract]
  • Hogg RJ; Adolescents with proteinuria and/or the nephrotic syndrome. Adolesc Med Clin. 2005 Feb;16(1):163-72. [abstract]
Acknowledgements EMIS is grateful to Dr Sean Kavanagh for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 2505
Document Version: 21
DocRef: bgp676
Last Updated: 2 Feb 2007
Review Date: 1 Feb 2009






















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page